Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies.
about
The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implicationsDeregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targetsGlioblastoma cancer stem cells: Biomarker and therapeutic advancesEstablishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion ModelUpregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H⁺ extrusion, cell migration and survival.Immunocompetent murine models for the study of glioblastoma immunotherapyMolecular targeting of glioblastoma: Drug discovery and therapiesMulticolor multicycle molecular profiling with quantum dots for single-cell analysisIsolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones.PDE7B is a novel, prognostically significant mediator of glioblastoma growth whose expression is regulated by endothelial cellsStrong expression of CD133 is associated with increased cholangiocarcinoma progressionIsolation, cultivation and identification of brain glioma stem cells by magnetic bead sortingMicro-environment causes reversible changes in DNA methylation and mRNA expression profiles in patient-derived glioma stem cellsDiscovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell PopulationsGlioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.Glioma revisited: from neurogenesis and cancer stem cells to the epigenetic regulation of the nicheChemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair.CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.Single-cell protein secretomic signatures as potential correlates to tumor cell lineage evolution and cell-cell interaction.Inhibition of Na(+)-K(+)-2Cl(-) cotransporter isoform 1 accelerates temozolomide-mediated apoptosis in glioblastoma cancer cellsMEF promotes stemness in the pathogenesis of gliomas.Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastomaSynchronous multicentric glioblastoma with PNET and O subtypes: Possible pathogenesisAssociation of collagen architecture with glioblastoma patient survival.The tissue-specific stem cell as a target for chemoprevention.Glioblastoma stem-like cells-biology and therapeutic implications.Deregulated microRNAs identified in isolated glioblastoma stem cells: an overview.Could magnetic resonance provide in vivo histology?Implications of mitogen-activated protein kinase signaling in glioma.Notch3 signaling-mediated melanoma-endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis.Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges.Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45.A mesenchymal glioma stem cell profile is related to clinical outcome.mGlu Receptors and Cancerous Growth.miR-204 suppresses the development and progression of human glioblastoma by targeting ATF2.Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme.Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins.Process of the Functional Reorganization of the Cortical Centers for Movement in GBM Patients: fMRI Study.Low Dose of Doxorubicin Potentiates the Effect of Temozolomide in Glioblastoma Cells.
P2860
Q26829663-9243F242-DA24-49BE-875A-A225812A03C1Q26829873-DAD10432-A02E-42B7-A179-8067FD7A8E28Q26859782-3310D9F2-691C-4D3E-8F74-09E62A4C7FC2Q27333230-33D31D9F-A8BE-4D86-91E2-1A75B1B9C8DCQ30586379-AB7930FA-5FFF-45F8-AC4E-E83CBE161E47Q33574853-E787F32E-F8CF-4551-B752-E92A5FCC136AQ33911283-A865E45C-23D4-44D7-9F9C-E737AB2180EBQ33940052-E1BE1507-DDB6-4C6E-A1CB-1699DB2DB22DQ34047392-500670BD-0D0B-454B-AD2E-283046604F04Q34156231-0AB3680A-5BB2-4131-8580-C9C337C0E7FAQ34717467-9296FE6C-C0CD-4FB9-96F8-A7D812FB9D9BQ35123782-E2EB0B44-4BBE-4A7F-B56B-A12FEB88EE04Q35146816-D65B6CD0-BDB9-4A12-B4A1-FCE014C2072BQ35748846-6B11423B-11E1-4E2D-892E-BF65BFB3CF15Q35794896-34F0D324-5FE2-4EA3-9EF9-82456AC81AB9Q36225175-9F64164D-FA34-4980-8248-E2B835EB2D94Q36287703-05616A02-D9AA-49B6-801E-D36CE7270569Q36295548-629A0752-C35A-4A5D-825B-4741A13966F7Q36589648-8C20AC5F-4083-43AE-8093-79D6E007B1E3Q36701435-8A0E524D-30E6-4F91-8871-A974C4D315EFQ37267797-3C247F2F-42D5-4DEB-BB4E-D73B34452198Q37520595-10125BAF-53F3-477C-BBAF-2DDD535D34A6Q37715158-C788C9CA-A314-4DFF-BC37-386AA5838883Q37746387-E5D266E3-41FD-4934-A7EB-A6CD0FAA0C7CQ37810502-D45F6585-EE70-404F-9AA6-4A9BD7E63989Q37907078-C92ED9A4-2732-477D-A63F-8EA8C67C3422Q38057886-7E32A496-540C-4DEB-892C-8ADAE3A28159Q38181079-1F4589A2-0311-446E-B005-FF82BCDF199CQ38618205-FA3C56FB-D147-4B62-8B21-C0AEB13030CFQ38717772-2F0C7ACF-0906-46EB-BF72-A405A05C1F77Q38989377-C0401F1B-02EC-452D-A419-985296C43E67Q39252478-26505B04-F294-4B30-A797-356A1FDEE773Q39388462-5611D993-BB95-4B80-9126-1CACE5CECF20Q40058197-3D3EBA8F-1978-4934-8211-CEF0F26D429BQ42019418-381878BD-AB4D-4F28-84DA-BB839021B0BDQ42173629-731AC14C-1B96-43C7-8BD6-CDA2B612F31DQ42715911-B393A232-8363-4059-B1DC-40925FBB71DAQ47235352-225EBE36-B911-4B32-B4BF-DA6318CC5D3DQ48171359-633B6799-732C-484E-8EE9-66F591C96C84Q48763582-FCCE6EAE-4052-4CD6-B02F-2BF4EA56E224
P2860
Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glioblastoma cancer stem cells ...... elated therapeutic strategies.
@en
Glioblastoma cancer stem cells ...... elated therapeutic strategies.
@nl
type
label
Glioblastoma cancer stem cells ...... elated therapeutic strategies.
@en
Glioblastoma cancer stem cells ...... elated therapeutic strategies.
@nl
prefLabel
Glioblastoma cancer stem cells ...... elated therapeutic strategies.
@en
Glioblastoma cancer stem cells ...... elated therapeutic strategies.
@nl
P2093
P50
P356
P1476
Glioblastoma cancer stem cells ...... related therapeutic strategies
@en
P2093
Antonio Melcarne
Carola Juenemann
Giuliano Faccani
Isabella Morra
Luisa Gennero
Maria Augusta Roos
Stefano Reguzzi
Tetyana Denysenko
P304
P356
10.1002/CBF.1666
P577
2010-07-01T00:00:00Z